TipRanks
Go Ultimate55% OFF

Biosyent (RX) Cash flow

Biosyent Cash Flow

TSE:RX's free cash flow for Q2 2026 was $2.54M. For the 2026 fiscal year, TSE:RX's free cash flow was decreased by $-17.02K and operating cash flow was $2.55M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 9.62M$ 8.66M$ 5.05M$ 4.95M$ 4.67M
$ 3.48M$ 3.29M$ 883.85K$ -10.79M$ -4.84M
$ -3.41M$ -7.83M$ -5.78M$ -4.37M$ -2.08M
$ 20.29M$ 12.11M$ 7.98M$ 7.86M$ 18.04M
$ 9.57M$ 3.99M$ 4.88M$ 4.43M$ 4.58M

Currency in CAD

Biosyent Cash Flow

-15M-10M-5M05M10M15M201720182019202020212022202320242025OperatingInvestingFinancing